|
| |
ChemGenex's Omacetaxine Shows Activity in Refractory CMLTuesday 9th of June 2009 12:54BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:
-
ChemGenex to Present Pivotal Data in T315I Positive CML Patients ... 14 May 2009 ... MELBOURNE, Australia & MENLO PARK, Calif.--(Business Wire)-- ChemGenex Pharmaceuticals Limited (ASX:CXS) (NASDAQ:CXSP) announced today that ...
http://www.reuters.com/article/pressRelease/idUS260300+14-Ma...
-
ChemGenex's Omacetaxine Kills Leukemic Stem Cells in Human CML ... 8 Jun 2009 ... New In Vitro Research with Omacetaxine in Human Cancer Stem Cells May Point to a Future Approach to Treating CML Jun 8, 2009 - ChemGenex ...
http://www.drugs.com/clinical_trials/chemgenex-s-omacetaxine...
-
ChemGenex to Seek Voluntary De-Listing From NASDAQ and to ... 29 Jun 2009 ... MELBOURNE, Australia & MENLO PARK, Calif.--(Business Wire)-- ChemGenex Pharmaceuticals Limited (ASX:CXS) advises that a decision has been ...
http://www.reuters.com/article/pressRelease/idUS10008+29-Jun...
-
ChemGenex Announces Shareholder Approval to Demerge Verva ... 29 Nov 2007 ... Nov 29, 2007 - ChemGenex Pharmaceuticals Limited (ASX CXS) and (NASDAQ CXSP) today announced that at the company s Annual General Meeting ...
http://www.drugs.com/news/chemgenex-announces-shareholder-ap...
-
ChemGenex Completes Capital Raising, Announces Rights Issue | Reuters 9 Apr 2009 ... A$10 Million Placement Completed A$7.4 Million Rights Issue Announced MELBOURNE, Australia & MENLO PARK, California--(Business Wire)-- ...
http://www.reuters.com/article/pressRelease/idUS90745+09-Apr...
-
ChemGenex's Omacetaxine Demonstrates Activity in CML Patients Who ... First Clinical Data from Ongoing Phase 2 Study Presented by Clinical Investigators at EHA Congress ChemGenex Pharmaceuticals (ASX CXS) (NASDAQ CXSP)
...
http://www.drugs.com/clinical_trials/chemgenex-s-omacetaxine...
-
ChemGenex Appoints Mr. Thomas DeZao as Senior Vice President and ... 20 Jul 2009 ... Key Appointment in Preparation for US Commercial Launch of Omacetaxine in 2010 MELBOURNE, Australia & MENLO PARK, Calif.
http://www.reuters.com/article/pressRelease/idUS88978+20-Jul...
-
ChemGenex Announces Second Publication Demonstrating Activity of ... Sep 24, 2007 - ChemGenex Pharmaceuticals Limited (ASX CXS and NASDAQ CXSP) announced today the publication of a clinical communication in Blood (the
journal ...
http://www.drugs.com/clinical_trials/chemgenex-announces-sec...
-
Pivotal Study Results: ChemGenex`s Omacetaxine May Provide the ... 1 Jun 2009 ... Data Intended for NDA Submission Presented at ASCO * Findings Suggest Omacetaxine Offers an Important Breakthrough in the Treatment of CML ...
http://www.reuters.com/article/pressRelease/idUS156878+01-Ju...
-
Pivotal Study Results: ChemGenex's Omacetaxine May Provide the ... 1 Jun 2009 ... Jun 1, 2009 - ChemGenex Pharmaceuticals Limited (ChemGenex) (ASX CXS) (NASDAQ CXSP) announced that the latest data from its pivotal study of ...
http://www.drugs.com/clinical_trials/pivotal-study-results-c...
 Related Web-Links(If any, Generated Automatically)
Source PR Newswire
www.prnewswire.co.uk Browse news from 2009
Download PDF 
|
